[HTML][HTML] Repetitive transcranial magnetic stimulation as a treatment for Alzheimer's disease: A randomized placebo-controlled double-blind clinical trial

Z Moussavi, M Uehara, G Rutherford, B Lithgow… - …, 2024 - Elsevier
We report results of a large multisite double-blind randomized trial investigating the short
and long-term efficacy of repetitive transcranial magnetic stimulation (rTMS) applied to …

Evaluating the Diagnostic Value of Electrovestibulography (EVestG) in Alzheimer's Patients with Mixed Pathology: A Pilot Study

ZA Dastgheib, BJ Lithgow, ZK Moussavi - Medicina, 2023 - mdpi.com
Background and Objectives: Diagnosis of dementia subtypes caused by different brain
pathophysiologies, particularly Alzheimer's disease (AD) from AD mixed with levels of …

Using principal component analysis to determine which vestibular stimuli provide best biomarkers for separating Alzheimer's from mixed Alzheimer's disease

S Marzban, Z Dastgheib, B Lithgow… - Medical & Biological …, 2024 - Springer
Alzheimer's disease (AD) is often mixed with cerebrovascular disease (AD-CVD).
Heterogeneity of dementia etiology and the overlapping of neuropathological features of AD …

Gray and White Matter Voxel-Based Morphometry of Alzheimer's Disease With and Without Significant Cerebrovascular Pathologies

C Saha, CR Figley, Z Dastgheib… - Neuroscience …, 2024 - journals.sagepub.com
Alzheimer's disease (AD) is the most common type of dementia, and AD individuals often
present significant cerebrovascular disease (CVD) symptomology. AD with significant levels …

Repetitive Transcranial Magnetic Stimulation as a Treatment for Alzheimer's Disease: A Randomized Placebo-Controlled Double-Blind Clinical Trial

Z Moussavi, M Uehara, G Rutherford, B Lithgow… - 2024 - researchsquare.com
We report results of a large multisite double-blind randomized trial investigating the short
and long-term efficacy of repetitive transcranial magnetic stimulation (rTMS) applied to …

A novel anxiety process biomarker via electrovestibulography

C Bosecke - 2022 - mspace.lib.umanitoba.ca
Anxiety disorders have no known biomarkers, and are thus diagnosed based on symptoms.
Identifying biomarkers for these disorders could help improve the accuracy of anxiety …